Do you use Monte Carlo simulations in your ER work? If so, what are the applications and programming software you normally use? Looking to get a feel for how commonly this and other analytic approaches are for valuation.
| +72 | Q&A - Buyside Equity Research Analyst/PM | 27 | 5d | |
| +31 | How the heck do you learn all of this stuff? | 5 | 2d | |
| +28 | Getting Frustrated | 10 | 2w | |
| +27 | My experience on the sell side | 20 | 1w | |
| +22 | What’s my next move? | 6 | 2w | |
| +20 | CS Major looking to switch and break into high finance - is it over for me? | 6 | 3w | |
| +20 | Vanderbilt vs. Notre Dame M.S. in Finance Equity Research placement | 10 | 3w | |
| +18 | Biotech ER vs IB | 16 | 2w | |
| +14 | Heard they don’t model at Oppenheimer | 10 | 1w | |
| +13 | ER time line and ways to break in help | 17 | 2w |
Career Resources
Get instant access to lessons taught by experienced private equity pros and bulge bracket investment bankers including financial statement modeling, DCF, M&A, LBO, Comps and Excel Modeling.
Hey epharm, what a lonely thread. I'm here since nobody responded ...so maybe one of these discussions will help:
More suggestions...
You're welcome.
We are happy with coming up with random target price and tell investors what the implied multiple is. Why get so scientific?
I've seen it used in a couple of very specific situations: valuing O&G exploration companies (where you are drilling a series of prospects with a rough idea of % chance of success on each and the probabiltiy distribution, plus there is some path dependency) or early stage pharma (similar).
For most companies - what would the point be? You're trying to value a company based on fundamentals, unless you're going to start putting together probability distributions for what the revenue line looks like (which would be garbage in / garbage out) there's nothing to 'simulate'.
Thanks for sharing your thoughts. I was mainly thinking it might apply to the probability of success for a pharma company’s trial or for a valuation of an early-stage pharma company.
If you have a very good idea of the % chance of success of each drug in a company's development pipeline at each stage of approval, and there are a few different drugs in the pipeline, then yeah running a Monte Carlo simulation could make some sense.
I'm not a pharma investor but I'd be amazed if you ever have enough information on the probabilities to make Monte Carlo anything other than garbage in / garbage out.
Okay thanks! Helpful to know.
Qui ab ut cumque fugiat occaecati quo. Aliquam ab ut ipsam et ea aperiam reprehenderit. Sunt possimus odio culpa deserunt explicabo consectetur. Ipsum architecto aut ducimus ut. Aut quasi eos et distinctio qui fugit. Ut sunt numquam nostrum quod nihil.
Sit ex beatae distinctio enim placeat consequatur eveniet. Excepturi nisi tenetur provident voluptatem vel ipsa. Id est occaecati dolorum id vel.
Harum enim consequatur ipsum. In dolores fuga et. Dolores beatae tempore eveniet et.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...